WhiteOak Capital Pharma and Healthcare Fund Direct Growth
3Y Annualised
N/A
1.00% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
3.98%
1.00% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
2 years 7 months
4 years 1 months
9 years 7 months
Fund info
Fund size
₹331.66 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹500
Exit load
0%
In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed/ switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
Fund Managers
About WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Pharma and Healthcare Fund Direct Growth is a Equity mutual fund scheme from WhiteOak Capital Asset Management Limited. This fund has been in existence for 1 years, having been launched on 2024-02-06. WhiteOak Capital Pharma and Healthcare Fund Direct Growth has ₹331.66 Cr worth of assets under management (AUM) as of Mon Jun 30 2025. The latest Net Asset Value (NAV) of WhiteOak Capital Pharma and Healthcare Fund Direct Growth as of Fri Jun 27 2025 is ₹13.782. The fund has an expense ratio of 0.68%, which is medium comparable to most other Equity funds.
WhiteOak Capital Pharma and Healthcare Fund Direct Growth returns for the last 1 year are 30.46%. Since launch, it has delivered 26.00% average annual returns.
The WhiteOak Capital Pharma and Healthcare Fund Direct Growth has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of WhiteOak Capital Pharma and Healthcare Fund Direct Growth.
- Sun Pharmaceuticals Industries Ltd: 8.76%
- Divi's Laboratories Ltd: 7.76%
- Max Healthcare Institute Ltd Ordinary Shares: 7.52%
- Cipla Ltd: 5.66%
- Fortis Healthcare Ltd: 5.12%
AMC Information
| Name | WhiteOak Capital Asset Management Limited |
|---|---|
| Founding Date | 2024-02-06 |
| Phone | +91 180030003060 |
| Website | http://mf.whiteoakamc.com |
| Address | 602B, 6th Floor,Indiabulls Finance Centre(IFC),1&2 Senapati Bapat Marg, Elphinstone Road (West) Mumbai Mumbai City |
Tax Implications of WhiteOak Capital Pharma and Healthcare Fund Direct Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from WhiteOak Capital Asset Management Limited
Money MarketLiquid
3Y CAGR
6.79%
expense ratio
0.31%
fund size
₹456.12 Cr
Money MarketLiquid
3Y CAGR
6.90%
expense ratio
0.21%
fund size
₹456.12 Cr
Fixed IncomeUltra Short Duration
3Y CAGR
7.09%
expense ratio
0.47%
fund size
₹486.32 Cr
Fixed IncomeUltra Short Duration
3Y CAGR
6.46%
expense ratio
1.02%
fund size
₹486.32 Cr
EquityLarge-Cap
3Y CAGR
0%
expense ratio
2.20%
fund size
₹924.57 Cr
FAQs
What is the current NAV of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
What are the average returns of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
How do I invest in WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
What is the expense ratio of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
What are net assets under management (AUM) of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
What is the PE and PB ratio of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
What are the top 5 holdings of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
What are the top 3 sectors that WhiteOak Capital Pharma and Healthcare Fund Direct Growth has invested in?
Who is the manager of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
What is the exit load of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
How to Redeem WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
Can I invest in SIP and a Lump Sum of WhiteOak Capital Pharma and Healthcare Fund Direct Growth?
